Brief: Epigenomics FY 2015 total revenue up by 38 pct to 2.1 mln euros

Epigenomics AG

18/03/2016 05:00

March 18 (Reuters) - Epigenomics AG  ECXn.DE : 
    * Revenue estimate for 2016 is expected in range of 3 
million to 7 million with bulk of this in second half of year 
    * For 2017 and years to come, cash utilization for 
operating and investing activities is expected to decrease along 
with revenues ramping up 
    * FY total revenue up by 38 pct to 2.1 million euros ($2.37 
million), operating loss (EBIT) increased to -9.3 mln euros 
(2014: -8.4 million euros), company's liquidity at year-end 2015 
was 8.6 million euros 
    * Expects EBIT for 2016 to be lower than in 2015, in range 
of -9.0 mln to -11.0 million euros 
 
Source text for Eikon:  ID:nEQ3HSvgRa  
Further company coverage:  ECXn.DE  
 
($1 = 0.8843 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))